Skip to main content
Metal-Based Drugs logoLink to Metal-Based Drugs
. 1994;1(2-3):183–193. doi: 10.1155/MBD.1994.183

Degradation of Anthracycline Antitumor Compounds Catalysed by Metal Ions

Marina M L Fiallo 1,, Hayet Tayeb-Bel Haj 1, Arlette Garnier-Suillerot 1
PMCID: PMC2364892  PMID: 18476230

Abstract

The influence of some metal ions on the degradation of anthracyclines was examined. One of the degradation products is the 7,8-dehydro-9,10-desacetyldoxorubicinone, D* (¥), usually formed by hydrolysis at slightly basic pH. D* is a lipophilic compound with no cytostatic properties. Its formation could be responsible for the lack of antitumor activity of the parent compound. The coordination of metal ions to anthracycline derivatives is required to have degradation products. Cations such as Na+, K+, or Ca2+ do not induce the D* formation however metals which can form stable complexes with doxorubicin afford D*. Iron(III) and copper(II) form appreciable amount of D* at slightly acidic pH. Terbium(III) forms D* but its complex is stable only at slightly basic pH. Palladium(II) which does not form D*. The influence of the coordination mode of metal ions to anthracycline on the D* formation is discussed.

Full Text

The Full Text of this article is available as a PDF (881.2 KB).


Articles from Metal-Based Drugs are provided here courtesy of Wiley

RESOURCES